Premera Blue Cross is to pilot the Quell wearable pain relief device within NeuroMetrix. Through this collaboration, Premera will provide Quell devices to selected employees with chronic pain.
The pilot will assess employees’ response to the technology and its impact on their pain and quality of life. The pilot will also analyse numerous objective data points including device utilisation and sleep metrics that are automatically captured via Quell’s smartphone app.
Shai N Gozani, president and chief executive officer of NeuroMetrix, says, “We believe that this initiative could show the value of providing this drug-free, cost effective technology for employees suffering from chronic pain conditions that affect their quality of life and productivity.”
“The Healthcare Incubation Lab at Premera is committed to supporting health innovation and we are excited to learn how this might help our employees better manage chronic pain,” says Katy Greve, Premera’s director of Strategic Innovation. “Quell’s connectivity provides a unique opportunity to leverage data that we hope will help us assess how wearable devices could improve the lives of our employees and customers” she adds.
